Baker Bros. Advisors’s Crinetics Pharmaceuticals CRNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.05M | Buy |
|
|||||
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $5.31M | Hold |
|
|||||
|
2024
Q2 | $4.65M | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $14.4M | Sell |
|
|||||
|
2022
Q2 | $15.4M | Hold |
|
|||||
|
2022
Q1 | $18.2M | Hold |
|
|||||
|
2021
Q4 | $23.5M | Sell |
|
|||||
|
2021
Q3 | $19.4M | Hold |
|
|||||
|
2021
Q2 | $17.4M | Buy |
|
|||||
|
2021
Q1 | $9.42M | Hold |
|
|||||
|
2020
Q4 | $8.7M | Buy |
|
|||||
|
2020
Q3 | $4.74M | Sell |
|
|||||
|
2020
Q2 | $5.57M | Buy |
|
|||||
|
2020
Q1 | $2.57M | Hold |
|
|||||
|
2019
Q4 | $4.39M | Hold |
|
|||||
|
2019
Q3 | $2.63M | Buy |
|
|||||
|
2019
Q2 | $3.33M | Buy |
|
|||||
|
2019
Q1 | $2.99M | Hold |
|
|||||
|
2018
Q4 | $3.94M | Hold |
|
|||||
|
2018
Q3 | $3.76M | Buy |
|